Cardiac Rhythm Management
banner farapulse pulsed hrs2019

 

Activity Description

The webcast is comprised of proceedings from a satellite symposium at Heart Rhythm 2019.

This enduring educational activity features leading global experts who thoroughly examine the impact of Pulsed Field Ablation (PFA) for advancing the standard of care; including potential advantages over thermal modalities such as radiofrequency and cryoablation.

Cardiac Rhythm Management

Access Presentation

Webcast

Click on the session title listed below to view each portion of the activity.

For those wishing to obtain your continuing medical education certification, access Earn CME Credit Tab at the conclusion of the webcast; select the appropriate answer to each posttest question, and successfully obtain the passing score as designated at the top of the test.

  Basics of Pulsed Field Ablation
tmb FarapulseHRS2019 PFA Jais pres

Pulsed Field Ablation: A Nonthermal Tissue-Selective Ablation Modality
Pierre Jais, MD

play-webcast

tmb FarapulseHRS2019 Overview Vivek pres2

Overview of Cardiac PFA Systems Currently Used in Preclinical/Clinical Studies
Vivek Reddy, MD

play-webcast

  Data and Results from Animal Experiments
tmb FarapulseHRS2019 Animal safgety Neven pres

Animal Safety Studies: The Utrecht Experience
Kars Neven, MD, PhD

play-webcast

tmb FarapulseHRS2019 Animal safgety Heines pres

Animal Studies: The Beaumont Experience
David Haines, MD

play-webcast

tmb FarapulseHRS2019 PV SVC Jais pres

PV and SVC Isolation; Linear Lines; Safety Aspects: Bordeaux Preclinical Experience
Pierre Jais, MD

play-webcast

tmb FarapulseHRS2019 V Lesions Koruth pres

Ventricular Lesions; Safety Aspects
Jacob Koruth, MD

play-webcast

tmb FarapulseHRS2019 Panel pres

Panel Discussion

play-webcast

  Results in Patients
tmb FarapulseHRS2019 Human Exp Neven pres

Human Experience
Kars Neven, MD, PhD

play-webcast

tmb FarapulseHRS2019 Surgical Exp Hebeler pres

Surgical Experience: Results to Date and Looking Ahead
Robert Hebeler, MD

play-webcast

tmb FarapulseHRS2019 Endocardial Vivek pres1

Endocardial Experience
Vivek Reddy, MD

play-webcast

tmb FarapulseHRS2019 Roundtable pres

Roundtable Discussion
Moderators: Pierre Jais, MD and Vivek Reddy, MD
Panel: David Haines, MD, Robert Hebeler, MD, Jacob Koruth, MD, Petr Neuzil, MD, PhD, Kars Neven, MD, PhD, Atul Verma, MD

play-webcast

Cardiac Rhythm Management

Commercial Supporter

This activity is supported by an educational grant from FARAPULSE, INC.

Joint-Providers

MediaSphere Medical, LLC and Ciné-Med

 

Faculty

Program Chairs

   
Pierre Jais, MD
Central Hospital University of Bordeaux
Bordeaux, France
  Vivek Reddy, MD
The Mount Sinai Hospital
New York, NY


Faculty

   

David Haines, MD
Beaumont Hospital
Royal Oak, MI

Robert Hebeler, MD
Baylor University Medical Center
Dallas, TX

Jacob Koruth, MD
The Mount Sinai Hospital
New York, NY

 

Petr Neuzil, MD, PhD
Na Homolce Hospital
Prague, Czech Republic

Kars Neven, MD, PhD
Alfried Krupp von Bohlen und Halbach Krankenhaus
Essen, Germany

Atul Verma, MD
Southlake Regional Health Centre
Newmarket, ON, CA

 

CME Information

CME Released: 6/6/14/2019; Valid for credit through 6/6/2020

Target Audience

This activity is intended to meet the educational needs of electrophysiologists, cardiologists, fellows, and other physicians and associated healthcare professionals who are dedicated to the management of cardiac arrhythmias.

Activity Goal

This activity is designed to address the following ABMS/IOM competencies: Patient Care, Medical Knowledge, and Practice-Based Learning.

Learning Objectives

Upon completion of this activity, participants will be able to:

  • Review the basics of Pulsed Field Ablation.
  • Evaluate how PFA creates tissue lesions and how it is different from traditional energy sources with respect to side effects, risks and constraints.

Learn about what is known experimentally:

  • PFA for atrial lesions to isolate PVs / SVC.
  • PFA to create atrial linear lesions.
  • PFA for ventricular lesions.
  • PFA – safety aspects.
  • Results in patients, safety and efficacy from initial clinical trials.
  • Future developments with PFA.

Accreditation Statement

Jointly Accredited Provider TMThis activity has been planned and implemented by Ciné-Med and MediaSphere Medical. Ciné-Med is accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Physicians: Ciné-Med designates this enduring activity for a maximum of 1.5 AMA PRA Category 1Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses: Ciné-Med provides 1.5 Contact Hour for Nurses.

Disclosure Policy

MediaSphere Medical and Ciné-Med adheres to accreditation requirements regarding industry support of continuing medical education. Disclosure of the planning committee and faculty’s commercial relationships will be made known at the activity on course hand-outs and during faculty presentations. Speakers are required to openly disclose any limitations of data and/or any discussion of any off-label, experimental, or investigational uses of drugs or devices in their presentations.

All MediaSphere Medical and Ciné-Med employees in control of content have indicated that they have no relevant financial relationships to disclose.

It is the policy of MediaSphere Medical and Ciné-Med to ensure balance, independent objectivity, and scientific rigor in all its supported educational programs. All faculty members participating in educational activities are required to disclose to the program audience any real of apparent conflicts of interest held within the past 12 months.

MediaSphere Medical and Ciné-Med implement a mechanism to identify and resolve all conflicts of interest prior to delivering the educational activity to learners.  

Non Endorsement Statement

MediaSphere Medical and Ciné-Med verifies that sound education principles have been demonstrated in the development of this educational offering as evidenced by the review of its objectives, teaching plan, faculty, and activity evaluation process. MediaSphere Medical and Ciné-Med does not endorse or support the actual opinions or material content as presented by the speaker(s) and/or sponsoring organization.

Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. This activity is designed to be completed within the time designated on the title page; physicians and nurses should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™ or Contact Hours, you must receive a minimum score of 70% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read the target audience, learning objectives, and faculty disclosures.
  2. Review the educational presentations
  3. Select the appropriate answer to each posttest question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

Provider Contact Information

For technical support or CME/CE questions regarding this activity, please email us at This e-mail address is being protected from spambots. You need JavaScript enabled to view it .

Hardware/Software Requirements:

  • A computer with an Internet connection.
  • Internet Explorer 7.x or higher, Firefox 4.x or higher, Safari 2.x or higher, or any other W3C standards compliant browser.
  • Adobe Flash Player and/or an HTML5 capable browser may be required for video or audio playback.
  • Occasionally other additional software may be required such as PowerPoint or Adobe Acrobat Reader.

MediaSphere protects the privacy of personal and other information regarding participants, educational partners, and joint sponsors. MediaSphere and our joint sponsors will not release personally identifiable information to a third party without the individual’s consent, except such information as is required for reporting purposes to the appropriate accrediting agency. MediaSphere maintains physical, electronic, and procedural safeguards that comply with federal regulations to guard your nonpublic personal information.

Copyright © 2019 by MediaSphere Medical. All rights reserved. No part of this activity may be reproduced or transmitted in any form or by any means, electronic or mechanical, without first obtaining permission from MediaSphere Medical

 

CME/CE Test

CME/CE Test
  1. Cardiac Pulsed Field Ablation: State of the Art
  2. Please enter your information, and complete the following CME post test and evaluation form. Upon successful completion, your submission will be reviewed and you will receive notification shortly regarding the status of your certificate. You must achieve a minimum score of 70% to earn credit for this activity.

  3. First Name: *  
    Invalid Input
  4. Last Name: *  
    Invalid Input
  5. Primary Email Address: *  
    Invalid Input
  6. Degree: *  
    Invalid Input
  7. Institution: *  
    Invalid Input
  8. Mailing Address:*  
    Invalid Input
  9. City: *  
    Invalid Input
  10. State: *  
    Invalid Input

  11. 1. What are key contrasts with Pulse Field Ablation (PFA) as compared to the thermal modalities of radiofrequency and cryoablation?
  12. Select one*  





    Invalid Input Please Select one

  13. 2. Which of the following statement(s) is accurate surrounding problems and complications posed with thermal ablation?
  14. Select one*  








    Invalid Input Please Select one

  15. 3. When comparing the pathological effects of Radiofrequency Energy (RFA) vs. Pulsed Field Ablation (PFA) based upon pre-clinical results in an animal model; RFA shows evidence of “Sequesters” (asterisks), hemorrhage, thrombosis, and lipogranulomatous inflammation, whereas PFA shows homogeneous fibrosis, normal patent vessels, and normal epicardial fat.
  16. Select one*  


    Invalid Input Please Select one

  17. 4. The potential benefits of Pulsed Field Ablation include speed and adaptability as concluded by pre-clinical results in animal studies, including extremely fast deliveries vs RFA, and is applicable to simple and advanced approaches to ablation.
  18. Select one*  


    Invalid Input Please Select one

  19. 5. In the 10 patients of the first-in-human study investigating the feasibility and safety of PVI using irreversible electroporation, acute electrical PV isolation could be achieved safely by electroporation ablation using a custom 14-polar circular catheter.
  20. Select one*  


    Invalid Input Please Select one

  21. 6. The benefits of surgical PFA in patients with AF include that it is ultra-rapid, tissue-selective with no collateral damage, offers flexible positioning, and is off-pump.
  22. Select one*  


    Invalid Input Please Select one

  23. Although optional, we respectfully request that you complete the activity evaluation form, since your feedback assists in the development of future educational activities.

  24. Background

    Please rate each question using a scale of 1 to 5 (1 = Beginner, 5 = Advanced)


  25. I would consider my level of expertise in the subject matter prior to the webcast as:
    Invalid Input Please Select one

  26. I would consider my level of expertise in the subject matter after the activity
    Invalid Input

  27. Considering my experience and background, the material presented was:
    Invalid Input Please Select one

  28. Extent to which activity met the identified objectives
    Please rate each question using a scale of 1 to 5 (1 = Not Met, 5 = Completely Met)

  29. Review the basics of Pulsed Field Ablation.
    Invalid Input Please Select one

  30. Evaluate how PFA creates tissue lesions and how it is different from traditional energy sources with respect to side effects, risks and constraints.
    Invalid Input Please Select one

  31. Information Presented
    Please evaluate the information that was presented by answering Yes, No, Maybe or Not Applicable

  32. Reinforced my current practice/treatment habits:
    Invalid Input Please Select one

  33. Will improve my practice/patient outcomes:
    Invalid Input Please Select one

  34. Enhanced my current knowledge base:
    Invalid Input Please Select one

  35. Provided new ideas or information that I expect to use:
    Invalid Input Please Select one

  36. Information gained from this conference will result in making a change in your practice:
    Invalid Input Please Select one

  37. Future activities on this subject matter is important to my practice:
    Invalid Input Please Select one

  38. Addressed a professional practice gap:
    Invalid Input Please Select one

  39. Was free of commercial bias/influence:
    Invalid Input Please Select one

  40. What barriers do you anticipate in incorporating best practices learned in this activity into clinical activities or quality improvement initiatives at your institution?
    Invalid Input

  41. What mechanisms can you identify to overcome these barriers?
    Invalid Input

  42. (*) Required Fields
  43. Invalid Input

Cardiac Rhythm Management